Awareness and Perception of AI in Diabetes Care among Libyan Physicians at Benghazi Medical Center, Benghazi, Libya

Read full text Summarise with VIRAT
Authors: Sami A. Lawgaly, Najat Omer Buzaid
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Artificial intelligence (AI) is an emerging and efficient tool for diabetes management in many aspects. These aspects include predicting diabetes risk, blood glucose monitoring, screening of retinopathy, and dose adjustment. Objective: To evaluate the knowledge among Libyan physicians regarding the use of AI and their experience and opinion regarding applying AI in diabetes care. Methods: A cross-sectional study was conducted using an electronic questionnaire developed from a literature review. The questionnaire demonstrated good internal consistency (Cronbach’s alpha = 0.8). Participants were 74 physicians working at Benghazi Medical Center. It included demographic characteristics, knowledge, opinion, and concerns regarding the use of AI in diabetes care. Data was expressed as mean, standard deviation, frequencies, and chi-square. Results: Mean age was 38 years (range: 28–60). Years of experience varied, with 30 (40.5%) having less than 5 years, 20 (27.0%) having between 5 and 10 years, and 24 (32.4%) having over a decade of experience. In addition, 21 (28.4%) were specialized in diabetes, 63 (85.1%) were residents, and 11 (14.9%) were consultants and specialists. Notably, only one-third were familiar with AI in diabetes care, and familiarity was higher among those who specialized in diabetes ( p = 0.018). The knowledge score for specific tools in AI for diabetes care was low, 17/74 (22.97%). AI users had a positive perception of AI in diabetes care ( p = 0.045). A 55 (74.3%) found that AI can enhance patient self-management, while more than 60% were worried about the safety and reliability of AI information. Conclusion: Although the overall knowledge about the use of AI in diabetes care was low, most participants had a positive perception toward AI use, with more than half having worries regarding the accuracy of AI and the confidentiality of patients’ information. Publication History Article published online: 25 March 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

Fields of Study & Subjects

Artificial Intelligence in Healthcare and Education Artificial Intelligence in Healthcare Diabetes Management and Research

Publication details

Journal / source
Ibnosina Journal of Medicine and Biomedical Sciences
Volume
18
Publication date
1 March 2026
Language
EN